Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00082732 | Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer | ||
| NCT02131584 | Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia | ||
| NCT01550900 | Prospective Trial of Metformin - Chemoprevention Role | ||
| NCT06711965 | Interactive Design of Patient-Specific Molds for Tissue Shaping | ||
| NCT05766891 | Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery | ||
| NCT06843720 | Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems | ||
| NCT00038675 | Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | ||
| NCT02140021 | Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer | ||
| NCT06096506 | Nourishing the Community Through Culinary Medicine - Acres Homes | ||
| NCT02815995 | Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes | ||
| NCT04058964 | Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer | ||
| NCT00473798 | Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer | ||
| NCT00960726 | NOV-002 in Myelodysplastic Syndrome (MDS) | ||
| NCT00634010 | Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain | ||
| NCT04188418 | Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients | ||
| NCT05634525 | Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients | ||
| NCT00569010 | Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) | ||
| NCT01952847 | Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis | ||
| NCT07257055 | Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study | ||
| NCT02363491 | A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome | ||
| NCT00575718 | Smoking Cessation Intervention for Cancer Patients | ||
| NCT00506233 | Feasibility Study of Collecting Multicenter Chronic GVHD Data | ||
| NCT00656448 | A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS | ||
| NCT00065143 | Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome | ||
| NCT00452374 | Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL | ||
| NCT01478074 | ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia | ||
| NCT00848289 | Genetic Susceptibility to Bladder Cancer | ||
| NCT00489814 | Study of Quality of Life for Prostate Proton Therapy | ||
| NCT00928161 | Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy | ||
| NCT03610490 | Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma | ||
| NCT00502203 | Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus | ||
| NCT00507923 | Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer | ||
| NCT00429182 | Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | ||
| NCT04592250 | Financial Toxicity in Cancer Patients | ||
| NCT04563806 | Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery | ||
| NCT00427336 | Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia | ||
| NCT03629171 | Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia | ||
| NCT04940299 | Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma | ||
| NCT01492049 | R-21 Colorectal Cancer Screening (CRCS) Pilot Trial | ||
| NCT00038844 | Safety and Efficacy of Campath in Nonmyeloablative Transplantation | ||
| NCT05038852 | Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study | ||
| NCT02633111 | DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas | ||
| NCT04407247 | Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma | ||
| NCT04965714 | Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer | ||
| NCT00561444 | Quality of Life Study for Prostate Cancer Patients | ||
| NCT01200485 | Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 | ||
| NCT00942734 | Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma | ||
| NCT06409052 | Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women | ||
| NCT04555577 | Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma | ||
| NCT06563375 | Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors |
